Pierre R. Breber
At a glance: Pierre R. Breber is Director at Clorox (CLX). Their latest SEC Form 4, filed Nov 5, 2026, reported a purchase of $400K. On file: 3 purchase lines ($1.2M) and 0 sale lines ($0).
Disclosed holdings: about $2.3M of CLX stock: 22,000 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 20, 2026 close of $106.23. This counts only CLX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Clorox Co /De/ (CLX)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
Pierre R. Breber's InsiderPrint
6 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about 4 times a year, typically $429K a trade; trades in the same month most years.
- Bump outward: a purchase (6)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- James T. Glerum Jr.Director · AMCR · 99% match
- Neal C. Bradsher10% Owner · IMDX · 97% match
- Broadwood Capital Inc10% Owner · IMDX · 97% match
- Broadwood Partners, L.P.10% Owner · IMDX · 97% match
- Matthew WilksCEO · ACDC · 97% matchTheir buys since 2023: 2 of 8 beat the S&P 500
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2025
From the SEC's insider data sets: each open-market buy by Pierre R. Breber, matched to how the stock did over the next 90 days against the S&P 500.
2 of 3 buys beat the S&P 500 (67%), median +9.2% vs. the index. Small sample: treat with care. All insider buys: 46%.
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 5SEC | CLXClorox Co /De/Past buys 2/3 beat S&P | Buy | 4,00022,000 held (+22%) | $100.06 | $400K | +6.2% |
| May 5SEC | CLXClorox Co /De/Past buys 2/3 beat S&P | Buy | 5,00018,000 held (+38%) | $85.82 | $429K | +23.8% |
| Nov 24SEC | CLXClorox Co /De/Past buys 2/3 beat S&P | Buy | 4,00013,000 held (+44%) | $104.13 | $417K | +2.0% |
- Buy
Director Pierre R Breber bought $400K of CLX at $100.06 — raises the stake by 22%.
- Buy
Director Pierre R Breber bought $429K of CLX at $85.82 — raises the stake by 38%.
- Buy
Director Pierre R Breber bought $417K of CLX at $104.13 — first open-market purchase in our records; raises the stake by 44%.
Follow Pierre R. Breber
Get one email when Pierre R. Breber files a new purchase or sale. Free.
At most one email a day about Pierre R. Breber, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.